Literature DB >> 17617665

A chemical proteomics approach to phosphatidylinositol 3-kinase signaling in macrophages.

Christian Pasquali1, Dominique Bertschy-Meier, Christian Chabert, Marie-Laure Curchod, Christian Arod, Randy Booth, Karl Mechtler, Francis Vilbois, Ioannis Xenarios, Colin G Ferguson, Glenn D Prestwich, Montserrat Camps, Christian Rommel.   

Abstract

Prior work using lipid-based affinity matrices has been done to investigate distinct sets of lipid-binding proteins, and one series of experiments has proven successful in mammalian cells for the proteome-wide identification of lipid-binding proteins. However, most lipid-based proteomics screens require scaled up sample preparation, are often composed of multiple cell types, and are not adapted for simultaneous signal transduction studies. Herein we provide a chemical proteomics strategy that uses cleavable lipid "baits" with broad applicability to diverse biological samples. The novel baits were designed to avoid preparative steps to allow functional proteomics studies when the biological source is a limiting factor. Validation of the chemical baits was first confirmed by the selective isolation of several known endogenous phosphatidylinositol 3-kinase signaling proteins using primary bone marrow-derived macrophages. The use of this technique for cellular proteomics and MS/MS analysis was then demonstrated by the identification of known and potential novel lipid-binding proteins that was confirmed in vitro for several proteins by direct lipid-protein interactions. Further to the identification, the method is also compatible with subsequent signal transduction studies, notably for protein kinase profiling of the isolated lipid-bound protein complexes. Taken together, this integration of minimal scale proteomics, lipid chemistry, and activity-based readouts provides a significant advancement in the ability to identify and study the lipid proteome of single, relevant cell types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617665     DOI: 10.1074/mcp.T600066-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  11 in total

1.  Phosphatidylinositol 3,4,5-trisphosphate activity probes for the labeling and proteomic characterization of protein binding partners.

Authors:  Meng M Rowland; Heidi E Bostic; Denghuang Gong; Anna E Speers; Nathan Lucas; Wonhwa Cho; Benjamin F Cravatt; Michael D Best
Journal:  Biochemistry       Date:  2011-11-30       Impact factor: 3.162

Review 2.  The role of targeted chemical proteomics in pharmacology.

Authors:  Chris W Sutton
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Integrin-linked kinase regulates integrin signaling in human trabecular meshwork cells.

Authors:  Jennifer A Faralli; Jessica R Newman; Nader Sheibani; Shoukat Dedhar; Donna M Peters
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-25       Impact factor: 4.799

4.  A screen for novel phosphoinositide 3-kinase effector proteins.

Authors:  Miles J Dixon; Alexander Gray; François-Michel Boisvert; Mark Agacan; Nicholas A Morrice; Robert Gourlay; Nicholas R Leslie; C Peter Downes; Ian H Batty
Journal:  Mol Cell Proteomics       Date:  2011-01-24       Impact factor: 5.911

5.  Microarray analysis of Akt PH domain binding employing synthetic biotinylated analogs of all seven phosphoinositide headgroup isomers.

Authors:  Meng M Rowland; Denghuang Gong; Heidi E Bostic; Nathan Lucas; Wonhwa Cho; Michael D Best
Journal:  Chem Phys Lipids       Date:  2011-12-08       Impact factor: 3.329

Review 6.  The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!

Authors:  Sara A Wickström; Anika Lange; Eloi Montanez; Reinhard Fässler
Journal:  EMBO J       Date:  2009-12-24       Impact factor: 11.598

7.  Activated Integrin-Linked Kinase Negatively Regulates Muscle Cell Enhancement Factor 2C in C2C12 Cells.

Authors:  Zhenguo Dong; Wei Pan; Haiqing Wu; Dongjun Liu; Ming Cang
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

Review 8.  Role of integrin alpha4 in drug resistance of leukemia.

Authors:  Stephanie Shishido; Halvard Bönig; Yong-Mi Kim
Journal:  Front Oncol       Date:  2014-05-23       Impact factor: 6.244

9.  Diverse integrin adhesion stoichiometries caused by varied actomyosin activity.

Authors:  Natalia A Bulgakova; Jutta Wellmann; Nicholas H Brown
Journal:  Open Biol       Date:  2017-04       Impact factor: 6.411

10.  Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.

Authors:  Juxiang Cao; Jennifer Schulte; Alexander Knight; Nicholas R Leslie; Agnieszka Zagozdzon; Roderick Bronson; Yefim Manevich; Craig Beeson; Carola A Neumann
Journal:  EMBO J       Date:  2009-04-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.